# Mayo Clinic Hepatobiliary SPORE

> **NIH NIH P50** · MAYO CLINIC ROCHESTER · 2021 · $109,230

## Abstract

OVERALL – PROJECT SUMMARY
The Mayo Clinic Specialized Program of Research Excellence in Hepatobiliary Cancers builds upon four
exceptional and diverse translational projects and three well-constructed and responsive cores that, together,
promise substantial steps forward. In addition, our proposed Career Enhancement Program and
Developmental Research Program are designed with the utmost support. And finally, the Mayo Clinic, the
Mayo Clinic Cancer Center, and the SPORE programs, now underway at the institution, stand behind this
endeavor and will provide important support toward integrating resources, skilled staff, and leadership
guidance to ensure success. This confluence of expertise, resources, structure, and accountability will drive
the initial five years of the HBCs SPORE to achieve its intended goals. Our approach is comprehensive and
milestone-focused.
We look forward to working with NCI leadership, our partners, and our patients to make this program a
success.

## Key facts

- **NIH application ID:** 10411346
- **Project number:** 3P50CA210964-04S1
- **Recipient organization:** MAYO CLINIC ROCHESTER
- **Principal Investigator:** MARK A. MC NIVEN
- **Activity code:** P50 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $109,230
- **Award type:** 3
- **Project period:** 2018-09-10 → 2023-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10411346

## Citation

> US National Institutes of Health, RePORTER application 10411346, Mayo Clinic Hepatobiliary SPORE (3P50CA210964-04S1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10411346. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*